Clinical Trial Update: Dusquetide for the Treatment of Behcet's Disease [Phase 2]

View source ↗

Summary

Soligenix reports the completion of a Phase 2 trial evaluating dusquetide for Behçet's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Dusquetide (dusquetide)

Snippet

Sponsor: Soligenix | Conditions: Behçet Disease | Phase 2 | Status: COMPLETED